• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性脑桥胶质瘤患儿神经轴转移的发生率及模式

Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.

作者信息

Gururangan Sridharan, McLaughlin Colleen A, Brashears James, Watral Melody A, Provenzale James, Coleman R Edward, Halperin Edward C, Quinn Jennifer, Reardon David, Vredenburgh James, Friedman Allan, Friedman Henry S

机构信息

The Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

J Neurooncol. 2006 Apr;77(2):207-12. doi: 10.1007/s11060-005-9029-5.

DOI:10.1007/s11060-005-9029-5
PMID:16568209
Abstract

PURPOSE

We performed a retrospective study of patients with diffuse pontine glioma (DPG) who suffered neuraxis metastasis (NM) and characterized the incidence, clinical features, radiologic findings, and patterns of disease dissemination.

METHODS

Magnetic resonance imaging (MRI) of brain and spine was used to assess NM. Some patients also underwent magnetic resonance spectroscopy (MRS) (6 patients) and fluorodeoxyglucose positron emission tomography (FDG-PET) scans (13 patients) to further evaluate areas of metastatic disease. Three patients had histologic confirmation of disease at the site of NM.

RESULTS

Between 1986 and 2003, 18 of 96 patients (17.3%) with DPG developed NM. The median age at diagnosis was 8 years (range, 4-17). All patients had adjuvant chemotherapy and/or focal radiotherapy at diagnosis. The NM occurred at a median of 15 months from diagnosis of DPG (range, 3-96). Three patterns of NM were seen on MRI of brain and spine in these patients; 8 (39%) had parenchymal (PM), 4 (22%) leptomeningeal (PM), 2 (11%) subependymal, and in 5 a combination of two or more patterns. The MRS and FDG-PET scan of suspected areas of metastatic disease was consistent with tumor in 6 of 6 and 12 of 13 patients who underwent these procedures respectively. Three patients also had histologic confirmation of malignant glioma at the site of NM. Despite salvage therapy, all 18 patients have died of disease at a median of 5 months (range, 0.5-20) from diagnosis of neuraxis spread.

CONCLUSION

Our study emphasizes the need for screening patients with DPG for NM at the time of recurrence.

摘要

目的

我们对患有弥漫性脑桥胶质瘤(DPG)并发生神经轴转移(NM)的患者进行了一项回顾性研究,以确定其发生率、临床特征、影像学表现及疾病播散模式。

方法

采用脑部和脊柱的磁共振成像(MRI)评估NM。部分患者还接受了磁共振波谱分析(MRS)(6例患者)和氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)(13例患者),以进一步评估转移病灶区域。3例患者在NM部位有疾病的组织学确诊。

结果

1986年至2003年间,96例DPG患者中有18例(17.3%)发生了NM。诊断时的中位年龄为8岁(范围4 - 17岁)。所有患者在诊断时均接受了辅助化疗和/或局部放疗。NM发生在DPG诊断后的中位时间为15个月(范围3 - 96个月)。在这些患者的脑部和脊柱MRI上可见三种NM模式;8例(39%)为实质型(PM),4例(22%)为软脑膜型(LM),2例(11%)为室管膜下型,5例为两种或更多模式的组合。分别接受这些检查的6例和13例患者中,可疑转移病灶区域的MRS和FDG-PET扫描结果分别与6例中的6例和13例中的12例肿瘤情况相符。3例患者在NM部位也有恶性胶质瘤的组织学确诊。尽管进行了挽救性治疗,所有18例患者均在神经轴扩散诊断后的中位时间5个月(范围0.5 - 20个月)死于该疾病。

结论

我们的研究强调在复发时对DPG患者进行NM筛查的必要性。

相似文献

1
Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.弥漫性脑桥胶质瘤患儿神经轴转移的发生率及模式
J Neurooncol. 2006 Apr;77(2):207-12. doi: 10.1007/s11060-005-9029-5.
2
Leptomeninges as a site of relapse in locally controlled, diffuse pontine glioma with review of literature.
Childs Nerv Syst. 2007 Jan;23(1):117-21. doi: 10.1007/s00381-006-0168-6. Epub 2006 Sep 16.
3
Rare Diffuse Intrinsic Pontine Glioma Metastasis Throughout the Brain and Spine.罕见弥漫性脑桥内在神经胶质瘤脑和脊髓广泛转移。
World Neurosurg. 2020 Aug;140:301-302. doi: 10.1016/j.wneu.2020.05.205. Epub 2020 May 28.
4
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.18F-FDG与11C-蛋氨酸PET在疑似胶质瘤复发中的直接比较:敏感性、观察者间变异性及预后价值
Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):39-51. doi: 10.1007/s00259-004-1564-3. Epub 2004 Aug 10.
5
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.用于弥漫性脑桥胶质瘤的渗透性血脑屏障破坏化疗
J Neurooncol. 2006 May;77(3):279-84. doi: 10.1007/s11060-005-9038-4. Epub 2005 Nov 29.
6
18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.18-氟脱氧葡萄糖摄取与疑似复发性恶性胶质瘤患者的生存情况
Cancer. 1997 Jan 1;79(1):115-26.
7
Young age may predict a better outcome for children with diffuse pontine glioma.年龄较小可能预示着弥漫性脑桥胶质瘤患儿的预后较好。
Cancer. 2008 Aug 1;113(3):566-72. doi: 10.1002/cncr.23584.
8
Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.正电子发射断层扫描在儿童弥漫性脑桥内在型胶质瘤评估中的应用。
J Pediatr Hematol Oncol. 2011 Jul;33(5):369-73. doi: 10.1097/MPH.0b013e31820ad915.
9
Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.多参数磁共振成像(MRI)和氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)能否预测弥漫性脑干胶质瘤的预后?一项前瞻性II期研究报告。
Pediatr Neurosurg. 2013;49(5):274-81. doi: 10.1159/000366167. Epub 2014 Sep 25.
10
Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma.前瞻性中枢神经系统 MRI 监测显示弥漫性内在脑桥胶质瘤存在较高的软脑膜播散风险。
J Neurooncol. 2011 Mar;102(1):121-7. doi: 10.1007/s11060-010-0301-y. Epub 2010 Jul 10.

引用本文的文献

1
Patterns of relapse in diffuse intrinsic pontine glioma after convection-enhanced delivery of I-omburtamab.I-omburtamab对流增强递送后弥漫性脑桥内生型胶质瘤的复发模式
Neurooncol Adv. 2025 Jul 19;7(1):vdaf128. doi: 10.1093/noajnl/vdaf128. eCollection 2025 Jan-Dec.
2
High-Grade Temporal Ganglioglioma in an Older Adult Woman.老年女性的高级别颞叶节细胞胶质瘤
Cureus. 2023 Sep 24;15(9):e45862. doi: 10.7759/cureus.45862. eCollection 2023 Sep.
3
Spatially controlled construction of assembloids using bioprinting.使用生物打印技术进行空间控制组装体的构建。

本文引用的文献

1
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.接受放疗的小儿弥漫性脑干胶质瘤的纵向多体素磁共振波谱研究
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):20-31. doi: 10.1016/j.ijrobp.2004.09.027.
2
[18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma.
Neurosurgery. 2004 Dec;55(6):1280-8; discussion 1288-9. doi: 10.1227/01.neu.0000143027.41632.2b.
3
MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment.磁共振波谱在评估肿瘤治疗后后颅窝复发性强化病变中的应用
Nat Commun. 2023 Jul 19;14(1):4346. doi: 10.1038/s41467-023-40006-5.
4
Leptomeningeal dissemination in pediatric brain tumors.小儿脑瘤的软脑膜播散。
Neoplasia. 2023 May;39:100898. doi: 10.1016/j.neo.2023.100898. Epub 2023 Apr 1.
5
Towards Standardisation of a Diffuse Midline Glioma Patient-Derived Xenograft Mouse Model Based on Suspension Matrices for Preclinical Research.基于悬浮基质的弥漫性中线胶质瘤患者来源异种移植小鼠模型标准化用于临床前研究
Biomedicines. 2023 Feb 11;11(2):527. doi: 10.3390/biomedicines11020527.
6
H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics.H3K27 改变的弥漫性中线胶质瘤:直接递呈靶向治疗药物的范式转变机会。
Expert Opin Ther Targets. 2023 Jan;27(1):9-17. doi: 10.1080/14728222.2023.2177531. Epub 2023 Feb 12.
7
Immunotherapy approaches for the treatment of diffuse midline gliomas.免疫疗法在弥漫性中线胶质瘤治疗中的应用。
Oncoimmunology. 2022 Sep 26;11(1):2124058. doi: 10.1080/2162402X.2022.2124058. eCollection 2022.
8
Leptomeningeal disease and tumor dissemination in a murine diffuse intrinsic pontine glioma model: implications for the study of the tumor-cerebrospinal fluid-ependymal microenvironment.小鼠弥漫性脑桥内在型胶质瘤模型中的软脑膜疾病和肿瘤播散:对肿瘤-脑脊液-室管膜微环境研究的启示
Neurooncol Adv. 2022 Apr 26;4(1):vdac059. doi: 10.1093/noajnl/vdac059. eCollection 2022 Jan-Dec.
9
Disseminated diffuse midline glioma associated with poorly differentiated orbital lesion and metastases in an 8-year-old girl: case report and literature review.8 岁女孩伴弥散中线胶质瘤、未分化眶内病变及转移:病例报告及文献复习。
Childs Nerv Syst. 2022 Oct;38(10):2005-2010. doi: 10.1007/s00381-022-05530-7. Epub 2022 Apr 23.
10
Leptomeningeal and subependymal seeding of diffuse intrinsic pontine glioma: a case report.弥漫性内生桥脑胶质瘤的软脑膜和室管膜播散:一例报告。
Childs Nerv Syst. 2022 Aug;38(8):1643-1645. doi: 10.1007/s00381-022-05482-y. Epub 2022 Mar 15.
Neuroradiology. 2004 Jul;46(7):541-9. doi: 10.1007/s00234-004-1195-1. Epub 2004 Apr 23.
4
Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.小儿脑肿瘤进展的光谱和灌注磁共振成像预测指标
Cancer. 2004 Mar 15;100(6):1246-56. doi: 10.1002/cncr.20096.
5
Molecular mechanisms of glioma invasiveness: the role of proteases.胶质瘤侵袭性的分子机制:蛋白酶的作用
Nat Rev Cancer. 2003 Jul;3(7):489-501. doi: 10.1038/nrc1121.
6
Multivoxel magnetic resonance spectroscopy of brain tumors.脑肿瘤的多体素质子磁共振波谱分析
Mol Cancer Ther. 2003 May;2(5):497-507.
7
Positron emission tomography imaging of brain tumors.脑肿瘤的正电子发射断层扫描成像
Neuroimaging Clin N Am. 2002 Nov;12(4):615-26. doi: 10.1016/s1052-5149(02)00033-3.
8
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.将正电子发射断层扫描的应用扩展至高危神经母细胞瘤:氟-18氟脱氧葡萄糖正电子发射断层扫描作为患者随访中的唯一成像方式
J Clin Oncol. 2001 Jul 15;19(14):3397-405. doi: 10.1200/JCO.2001.19.14.3397.
9
Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses.使用18F-FDG PET基于视觉和感兴趣区的脑肿瘤分级比较:ROC分析
Eur J Nucl Med. 2001 Feb;28(2):165-74. doi: 10.1007/s002590000428.
10
Radiological evidence of glioma invasion of the central nervous system along tracts.
Surg Neurol. 2000 Aug;54(2):194-6. doi: 10.1016/s0090-3019(00)00280-9.